As of Mar 30
| +0.84 / +4.48%|
The 5 analysts offering 12-month price forecasts for Epizyme Inc have a median target of 42.00, with a high estimate of 45.00 and a low estimate of 23.00. The median estimate represents a +114.50% increase from the last price of 19.58.
The current consensus among 6 polled investment analysts is to Buy stock in Epizyme Inc. This rating has held steady since March, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.